EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Omics and Artificial Intelligence in Adult Sepsis: From Risk Stratification to Organ-Dysfunction Prediction and Individualized Therapy

Yanni Wang, Suibi Yang, Shengze Wu, Hongjie Shen, Jianhua Yang, Min Yang, Zhongheng Zhang

AI Medicine · 13.11.2026 · 3 (2)

DOI: 10.53941/aim.2026.100014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AI Medicine, online erschienen am 13.11.2026. Verfasst von Yanni Wang und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Fundamental Research Funds for the Central Universities, the Key Research & Development Project of Zhejiang Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis encompasses biologically distinct host-response states, organ-injury pathways, and treatment susceptibilities despite similar clinical presentations, limiting population-level diagnostic, prognostic, and therapeutic strategies. This review examines how multi-omics and artificial intelligence can support four connected tasks in adult sepsis: molecular phenotyping, risk stratification, early prediction of organ dysfunction, and individualized treatment. Transcriptomic and single-cell studies provide the most mature frameworks for defining immune states, while spatial transcriptomics, proteomics, metabolomics, and integrated multi-omics add tissue, functional, and organ-specific information. Artificial intelligence can integrate these signals with electronic health records and monitoring data to assign phenotypes and update dynamic risk. However, prediction does not establish treatment benefit, and current evidence remains dominated by retrospective analyses, small or single-center cohorts, inconsistent sampling, dataset shift, limited external validation, and sparse randomized evidence for biomarker- or AI-guided interventions. Progress will require standardized longitudinal sampling, multicenter validation, calibrated and explainable models, and prospective trials testing whether model-guided decisions improve patient-centered outcomes.

Förderung

  • the National Natural Science Foundation of China
  • the Fundamental Research Funds for the Central Universities
  • the Key Research & Development Project of Zhejiang Province
  • Beijing Municipal Natural Science Foundation
  • Wu Jieping Medical Foundation Special Research Grant

Zitieren

APA

Wang, Y., Yang, S., Wu, S., Shen, H., Yang, J., Yang, M., & Zhang, Z. (2026). Multi-Omics and Artificial Intelligence in Adult Sepsis: From Risk Stratification to Organ-Dysfunction Prediction and Individualized Therapy. AI Medicine, 3(2). https://doi.org/10.53941/aim.2026.100014

Vancouver

Wang Y, Yang S, Wu S, Shen H, Yang J, Yang M, et al. Multi-Omics and Artificial Intelligence in Adult Sepsis: From Risk Stratification to Organ-Dysfunction Prediction and Individualized Therapy. AI Medicine. 2026;3(2). doi:10.53941/aim.2026.100014

BibTeX
@article{Wang2026,
  author = {Wang, Yanni and Yang, Suibi and Wu, Shengze and Shen, Hongjie and Yang, Jianhua and Yang, Min and Zhang, Zhongheng},
  title = {Multi-Omics and Artificial Intelligence in Adult Sepsis: From Risk Stratification to Organ-Dysfunction Prediction and Individualized Therapy},
  journal = {AI Medicine},
  year = {2026},
  volume = {3},
  number = {2},
  doi = {10.53941/aim.2026.100014}
}
Kostenlos starten →